Study of WPV01 in Healthy Subjects

Clinical trial NCT06205329 · COMPLETED

Trial details

NCT number: NCT06205329
Sponsor: Westlake Pharmaceuticals (Hangzhou) Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Participants

Start date: 2022-10-03
Primary completion: 2023-03-11
Enrollment: 108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.